Glia as the “bad guys”: Implications for improving clinical pain control and the clinical utility of opioids
Top Cited Papers
- 18 December 2006
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 21 (2) , 131-146
- https://doi.org/10.1016/j.bbi.2006.10.011
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Spinal Glial Activation Contributes to Postoperative Mechanical Hypersensitivity in the RatThe Journal of Pain, 2006
- Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal hornFEBS Letters, 2006
- The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic painNeuron Glia Biology, 2006
- Interleukin-1αβ gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative painBehavioural Brain Research, 2006
- Viewing chemokines as a third major system of communication in the brainThe AAPS Journal, 2005
- Anterograde TNFα transport from rat dorsal root ganglion to spinal cord and injured sciatic nerveNeuroscience Letters, 2002
- Modulation of the expression of cyclooxygenase‐2 by fatty acids mediated through Toll‐like receptor 4‐derived signaling pathways1The FASEB Journal, 2001
- Dynamic regulation of the proinflammatory cytokine, interleukin-1β: Molecular biology for non-molecular biologistsLife Sciences, 1999
- Central neuron–glial and glial–glial interactions following axon injuryProgress in Neurobiology, 1998
- Opioid use in the treatment of chronic pain: Assessment of addictionJournal of Pain and Symptom Management, 1993